Skip to main content

Table 1 Doses of study medications

From: Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trial

 

Children aged 12–59 months

Children aged 5–14 years

SP tablet (500 mg + 25 mg)

A full tablet as a single dose on the 1st day of the SMC cycle

Two tablets as a single dose on the 1st day of the SMC cycle

AQ tablet (153 mg base)

A full tablet as a single daily dose for 3 consecutive days of the SMC cycle

Two tablets as a single daily dose for 3 consecutive days of the SMC cycle

 

Children aged 12–24 months

Children aged greater than 2 years and up to 14 years

ALB tablet (200 or 400 mg depending on age)

A half dose of albendazole 200 mg

A single dose of albendazole 400 mg

 

Children aged 1–14 years

 

PZQ tablet (600 mg)

Praziquantel based on their body weight 40 mg/kg

 

Vitamin A (200,000 IU)

Children aged 1–14 years

 
 

200,000 IU Vitamin A

 

Zinc (40 mg/kg)

Zinc supplement based on their body weight 40 mg/kg